Noveris Health Sciences Inc. (NVRS.CN) is trading 6.95% down today at $1.74 after announcing it received a notice from the Canadian Securities Exchange (CSE) that it must demonstrate compliance with continued listing requirements.
- The CSE has informed Noveris that if it fails to demonstrate compliance by the time it files financial statements for its nine-month period ending September 30, 2026, the ".X" inactive designation will be applied to its common shares.
- The company also stated it will not conduct any investor relations activities until it meets these requirements.
- This regulatory update contradicts the previous assessment of 'no fresh company news or regulatory updates' and provides a significant catalyst for today's price decline, following a period of speculative gains driven by easing British Columbia Securities Commission (BCSC) halt concerns earlier in the week.